The association between cytokine gene polymorphisms and the outcomes of chronic HBV infection

Hepatology Research

Volumn 36, Issue 3, 2006, Pages 158-166

  Li, Chen ^a   Zhi Xin, Chen ^a   Li Juan, Zhang ^a   Chen, Pan ^b   Xiao Zhong, Wang ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b Fuzhou Infectious Disease Hospital   (China)

Author keywords

Gene polymorphisms; Hepatitis B virus; Interleukin 10; Interleukin 6; Tumor necrosis factor

Indexed keywords

ALANINE; CYTOKINE; GLYCINE; INTERLEUKIN 10; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR ALPHA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCATION; GENETIC ASSOCIATION; GENETIC CODE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTCOME ASSESSMENT; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROMOTER REGION; SYMPTOMATOLOGY; VIRUS CARRIER; VIRUS INHIBITION;

EID: 33750071384     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2006.07.007     Document Type: Article

References (46)

1. Lee W.M. Hepatitis B virus infection. N Engl J Med 337 (1997) 1733-1745
2. Wang F.S. Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection. World J Gastroenterol 9 (2003) 641-644
3. Koziel M.J. Cytokines in viral hepatitis. Semin Liver Dis 150 (1999) 4659-4671
4. Juszczynski P., Kalinka E., Bienven J., et al. Human leukocyte antigens class II and tumor necrosis factor genetic polymorphisms are independent predictors of non-Hodgkin lymphoma outcome. Blood 100 (2002) 3037-3040
5. Kroeger K.M., Carville K.S., and Abraham T.J. The -308 tumor necrosis factor-alpha promoter polymorphisms effects transcription. Mol Immunol 34 (1997) 391-399
6. Asadullah K., Sterry W., and Volk H.D. Interleukin-10 therapy-review of a new approach. Pharmacol Rev 55 (2003) 241-269
7. Terry C.F., Loukaci V., and Green F.R. Cooperative influence of genetic polymorphisms on Interleukin 6 transcriptional regulation. J Bio Chem 275 (2000) 18138-18144
8. Edwards-Smith C.J., Jonsson J.R., Purdie D.M., et al. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology 30 (1999) 526-530
9. Knapp S., Hennig B.J., Frodsham A.J., et al. Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection. Immunogenetics 55 (2003) 362-369
10. Barrett S., Collins M., Kenny C., et al. Polymorphisms in tumour necrosis factor-alpha, transforming growth factor-beta, interleukin-10, interleukin-6, interferon-gamma, and outcome of hepatitis C virus infection. J Med Virol 71 (2003) 212-218
11. Ben-Ari Z., Mor E., papo O., et al. Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterol 98 (2003) 144-150
12. Hohler T., Kruger A., Gerken G., et al. A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clin Exp Immunol 111 (1998) 579-582
13. Chinese Society of Infectious Diseases and Parasitology and Chinese Society of Hepatology of Chinese Medical Association. The guideline for the prevention and therapy of viral hepatitis. Chin J Hepatol 2000;8:324-9
14. Chu C.J., Hussain M., and Lok A.S. Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology 122 (2002) 1756-1762
15. Kroeger K.M., Carville K.S., and Abraham T.J. The -308 tumor necrosis factor-alpha promoter polymorphisms effects transcription. Mol Immunol 34 (1997) 391-399
16. Skoog T., van't Hooft F.M., Kallini B., et al. A common functional polymorphisms (C → A substitution at position -863) in the promoter region of the tumor necrosis facto-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet 8 (1999) 1443-1449
17. Fishman D., Faulds G., Jeffery R., et al. The effect of novel polymorphisms in the Interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102 (1998) 1369-1376
18. Villeneuve J.P., Desrochers M., Infante-Rivard C., et al. A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal. Gastroenterology 106 (1994) 1000-1005
19. Franchis R.D., Meucci G., Vecchi M., et al. The natural history of asymptomatic hepatitis B surface antigen carriers. Ann Intern Med 118 (1993) 191-194
20. Guidotti L.G., Rosemary R., and Chung J. Viral clearance without destruction of infected cells during acute HBV infection. Science 284 (1999) 825-829
21. Romero R., and Lavine J.E. Cytokine inhibition of the hepatitis B virus core promoter. Hapatology 23 (1996) 17-23
22. Kim Y.J., Lee H.S., Yoon J.H., et al. Association of TNF-a promoter polymorphisms with the clearance of hepatitis B virus infection. Hum Mol Gene 12 (2003) 2541-2546
23. Thursz M. Genetic susceptibility in chronic viral hepatitis. Antiviral Res 52 (2001) 113-116
24. Hohler T., Gerken G., Notghi A., et al. HLA-DRB1*1301 and *1302 protect against chronic hepatitis B. J Hepatol 26 (1997) 503-507
25. Zhang P.A., Li Y., Xiang P.X., et al. Association of TNF-αgene promoter polymorphisms with outcome of hepatitis B virus infection. Shijie Huaren Xiaohua Zazhi 12 (2004) 2086-2090
26. Zhou Y.S., Wang F.S., Liu M.X., et al. Relationship between susceptibility of hepatitis B virus and gene polymorphism of tumor necrosis factor-α. Shijie Huaren Xiaohua Zazhi 13 (2004) 207-210
27. Powell E.E., Edwards-Smith C.J., Hay J.L., et al. Host genetic factors influence disease progression in chronic hepatitis C. Hepatology 31 (2000) 828-833
28. Constantini P.K., Awrzynowicz-Syczewska M.W., Clare M., et al. Interleukin-1, interleukin-10 and tumour necrosis factor-alpha gene polymorphisms in hepatitis C virus infection: an investigation of the relationships with spontaneous viral clearance and response to alpha-interferon therapy. Liver 22 (2002) 404-412
29. Jiang Y.G., Wang Y.M., Mao Q., et al. The comparative analysis between the polymorphism of HLA class II gene and TNF cytotoxicity in patients with hepatitis B. Chin J Infect Dis 23 (2005) 15-18
30. Lu L.P., Li X.W., Liu Y., et al. Association of -238G/A polymorphism of tumor necrosis factor-alpha gene promoter region with outcomes of hepatitis B virus infection in Chinese Han population. World J Gastroenterol 10 (2004) 1810-1814
31. Zein N.N., Germer J.J., Elzayadi A.R., et al. Ethnic difference in polymorphisms of tumor necrosis factor-α, interleukin-10, and transforming growth factor-β1 genes in patients with chronic hepatitis C virus infection. Am J Trop Med Hyg 70 (2004) 434-437
32. Meenagh A., Williams F., Ross O.A., et al. Frequency of cytokine polymorphisms in populations from Western Europe, Africa, Asia, the Middle East and South America. Hum Immunol 63 (2002) 1055-1061
33. Wang X.Z., Zhang L.J., Li D., et al. Effects of transmitters and interleukin-10 on rat hepatic fibrosis induced by CCl4. World J Gastroenterol 9 (2003) 539-543
34. Shu Q., Fang X., Chen Q., et al. IL-10 polymorphism is associated with increased incidence of severe sepsis. Chin Med J (Engl) 116 (2003) 1756-1759
35. Schaaf B.M., Boehmke F., Esnaashari H., et al. Pneumococcal septic shock is associated with the interleukin-10-1082 gene promoter polymorphism. Am J Respir Crit Care Med 168 (2003) 476-480
36. Chong W.P., Ip W.K., Wong W.H., et al. Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus. Genes Immun 5 (2004) 484-492
37. Nath S.K., Harley J.B., and Lee Y.H. Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: a meta-analysis. Hum Genet 27 (2005 Aug) 1-10
38. Font J., Garcia-Carrasco M., Ramos-Casals M., et al. The role of interleukin-10 promoter polymorphisms in the clinical expression of primary Sjogren's syndrome. Rheumatology (Oxford) 41 (2002) 1025-1030
39. Mangia A., Santoro R., Piattelli M., et al. IL-10 haplotypes as possible predictors of spontaneous clearance of HCV infection. Cytokine 25 (2004) 103-109
40. Miyazoe S., Hamasaki K., Nakata K., et al. Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus. Am J Gastroenterol 97 (2002) 2086-2092
41. Kim Y.J., Lee H.S., Im J.P., et al. Polymorphisms with a hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection. Exp Mol Med 35 (2003) 196-202
42. Streetz K.L., Luedde T., Manns M.P., et al. Interleukin 6 and liver regeneration. Gut 47 (2000) 309-312
43. Humphries S.E., Luong L.A., Ogg M.S., et al. The interleukin-6-174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J. 22 (2001) 2243-2252
44. Illig T., Bongardt F., Schopfer A., et al. Significant association of the Interleukin-6 gene polymorphisms C-174G and A-598G with Type 2 diabetes. J Clin Endo Meta 89 (2004) 5053-5058
45. Minton E.J., Smillie D., Smith P., et al. Clearance of hepatitis C virus is not associated with single nucleotide polymorphisms in the IL-1, -6, or -10 genes. Hum Immunol 66 (2005) 127-132
46. Park B.L., Lee H.S., Kim Y.J., et al. Association between interleukin-6 promoter variants and chronic hepatitis B progression. Exp Mol Med 35 (2003) 76-82